- Decision for Safe Discharge After Gastric Cancer Surgery: The Finale of Enhanced Recovery After Surgery Program
-
Choi YY
- KMID: 2535116
- J Gastric Cancer.
- 2022 Oct;22(4):261-263.
- doi: 10.5230/jgc.2022.22.e34
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017–2021)
-
Lee K, Suh M, Jun JK, Choi KS
- KMID: 2535115
- J Gastric Cancer.
- 2022 Oct;22(4):264-272.
- doi: 10.5230/jgc.2022.22.e36
Purpose: The coronavirus disease 2019 (COVID-19) pandemic has significantly disrupted cancer screening services worldwide. We aimed to measure the impact of COVID-19 on gastric cancer screening rates based on age,... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary Biomarkers for the Noninvasive Detection of Gastric Cancer
-
Li D, Yan L, Lin F, Yuan X, Yang X, Yang X, Wei L, Yang Y, Lu Y
- KMID: 2535114
- J Gastric Cancer.
- 2022 Oct;22(4):306-318.
- doi: 10.5230/jgc.2022.22.e28
Gastric cancer (GC) is associated with high morbidity and mortality rates. Thus, early diagnosis is important to improve disease prognosis. Endoscopic assessment represents the most reliable imaging method for GC... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Pathology of Gastric Cancer
-
Kim M, Seo AN
- KMID: 2535110
- J Gastric Cancer.
- 2022 Oct;22(4):273-305.
- doi: 10.5230/jgc.2022.22.e35
Gastric cancer (GC) is one of the most common lethal malignant neoplasms worldwide, with limited treatment options for both locally advanced and/or metastatic conditions, resulting in a dismal prognosis. Although... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
-
Sun B, Zhang H, Wang J, Cai H, Xuan Y, Xu D
- KMID: 2535109
- J Gastric Cancer.
- 2022 Oct;22(4):369-380.
- doi: 10.5230/jgc.2022.22.e29
Purpose: Tumor recurrence is the principal cause of poor outcomes in remnant gastric cancer (RGC) after resection. We sought to elucidate the recurrent patterns according to tumor locations in RGC. Materials... -
- CITED
-
- Close
- SHARE
-
- Close
- Apatinib as a Third-Line Treatment for HER2-Positive Metastatic Gastric Cancer: A Multi-Center Single-Arm Cohort Study
-
Zhang X, Huo H, Nie Y, Xue J, Yuan Z, Zhang Z
- KMID: 2535107
- J Gastric Cancer.
- 2022 Oct;22(4):408-417.
- doi: 10.5230/jgc.2022.22.e33
Purpose: Treatment options are limited after the failure of first-and second-line treatments in patients with HER2+ metastatic gastric cancer (mGC). The present study aimed to explore the efficacy, safety, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer
-
Guner A, Kim KY, Park SH, Cho M, Kim YM, Hyung WJ, Kim HI
- KMID: 2535111
- J Gastric Cancer.
- 2022 Oct;22(4):395-407.
- doi: 10.5230/jgc.2022.22.e32
Purpose: This study aimed to investigate the relationship between clinical and laboratory parameters and complication status to predict which patients can be safely discharged from the hospital on the third... -
- CITED
-
- Close
- SHARE
-
- Close
- PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p Binding
-
Dominkuš PP, Mesic A, Hudler P
- KMID: 2535112
- J Gastric Cancer.
- 2022 Oct;22(4):348-368.
- doi: 10.5230/jgc.2022.22.e31
Purpose: Chromosomal instability is a hallmark of gastric cancer (GC). It can be driven by single nucleotide variants (SNVs) in cell cycle genes. We investigated the associations between SNVs in... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Findings and Treatment of Gastric Neoplasms in Familial Adenomatous Polyposis
-
Sato C, Takahashi K, Sato H, Naruse T, Nakajima N, Takatsuna M, Mizuno Ki, Hashimoto S, Takeuchi M, Yokoyama J, Kobayashi M, Terai S
- KMID: 2535108
- J Gastric Cancer.
- 2022 Oct;22(4):381-394.
- doi: 10.5230/jgc.2022.22.e30
Purpose: Gastric neoplasia is a common manifestation of familial adenomatous polyposis (FAP). This study aimed to elucidate the clinical characteristics, endoscopic features including fundic gland polyposis (FGPsis), and treatment outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Extragastric Metastasis of Early Gastric Cancer After Endoscopic Submucosal Dissection With Lymphovascular Invasion and Negative Resected Margins
-
Lee HM, Kwak Y, Chung H, Kim SG, Cho SJ
- KMID: 2535113
- J Gastric Cancer.
- 2022 Oct;22(4):339-347.
- doi: 10.5230/jgc.2022.22.e27
Purpose: Lymphovascular invasion is a criterion for non-curative resection in patients who have undergone endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). We aimed to determine the rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- Sp1-Induced SETDB1 Overexpression Transcriptionally Inhibits HPGD in a β-Catenin-Dependent Manner and Promotes the Proliferation and Metastasis of Gastric Cancer
-
Fan Y, Yang L, Ren Y, Wu Y, Li L, Li L
- KMID: 2535106
- J Gastric Cancer.
- 2022 Oct;22(4):319-338.
- doi: 10.5230/jgc.2022.22.e26
Purpose: Gastric cancer (GC) has high morbidity and mortality, the cure rate of surgical treatment and drug chemotherapy is not ideal. Therefore, development of new treatment strategies is necessary. We... -
- CITED
-
- Close
- SHARE
-
- Close
